Investor Alert

New York Markets Close in:

Sept. 25, 2022, 10:45 p.m. EDT

Moderna Stock Stayed Flat as It Asked FDA to Approve Enhanced COVID Boosters for Kids.

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    Pfizer Inc. (PFE)
  • X
    BioNTech SE ADR (BNTX)

or Cancel Already have a watchlist? Log In

Sep 25, 2022 (PressReach.com via COMTEX) -- Moderna stock didn’t move much because the Centers for Disease Control and Prevention (CDC) intends to suggest updated vaccinations for children in one month. Moderna /zigman2/quotes/205619834/composite MRNA -3.83% has asked the Food and Drug Administration to approve its Omicron-adjusted booster doses for children.

Moderna ( NASDAQ:MRNA ), a biotechnology company based in Cambridge, Massachusetts, has put in two separate applications for emergency use authorization (EUA) for the vaccine known as mRNA-1273.222. The first application is for adolescents between the ages of 12 and 17, and the second is for children between the ages of 6 and 1.

The Food and Drug Administration gave its approval in August for an improved booster injection that was intended for those aged 18 and older. The original COVID strain and Omicron subvariants BA.4 and BA.5 have been added to the protection offered by the modified bivalent vaccination.

Both rival vaccine manufacturers, Pfizer /zigman2/quotes/202877789/composite PFE +0.18% and BioNTech /zigman2/quotes/214419716/composite BNTX -0.70% have received authorization from the FDA to use an improved version of their booster vaccination in people aged 12 and older.

PFE announced their plans to seek FDA permission for an Omicron-adapted booster aimed at children aged 5 to 11 at a conference at the CDC AdCom earlier this month. The meeting took place at the beginning of this month.

The Centers for Disease Control and Prevention (CDC) will hold sessions for its vaccine advisory group on October 19 and 20.

Earlier, it was reported by a federal health body that the United States government has sent over 25 million doses of updated COVID-19 booster injections. Most of these doses came from PFE and BNTX, and Moderna stock is working to increase its output.

Featured Image- Megapixl @ OceanProd

Please See Disclaimer

Visit PressReach.com To Get More Articles Like This

Author: Shariq Khan
Market Jar Media Inc.
#170 - 422 Richards Street
Vancouver, BC, Canada
V6B 2Z4


Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

US : U.S.: Nasdaq
$ 177.63
-7.07 -3.83%
Volume: 1.95M
Dec. 9, 2022 1:29p
P/E Ratio
Dividend Yield
Market Cap
$70.96 billion
Rev. per Employee
$ 51.88
+0.09 +0.18%
Volume: 9.15M
Dec. 9, 2022 1:29p
P/E Ratio
Dividend Yield
Market Cap
$290.66 billion
Rev. per Employee
US : U.S.: Nasdaq
$ 170.60
-1.21 -0.70%
Volume: 433,050
Dec. 9, 2022 1:28p
P/E Ratio
Dividend Yield
Market Cap
$41.70 billion
Rev. per Employee

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.